Back to Awarded Treatment Trials
Awarded Trial: 12T-004
Grant ID
12T-004
Illness
schizophrenia
Primary Drug/Intervention
tocilizumab
Primary Dosage
4mg/kg and 8mg/kg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Girgis
Sample Size
36
Duration of Study Period for Each Subject
90 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Ragy Girgis
Degree
MD
Center
New York State Psychiatric Institute
Institution
Columbia University
Address
1051 Riverside Drive, Unit 31
City or Town
New York
State or Province
NY
Zip or Postal Code
10032
Country
USA
Email Address
ragygir@nyspi.columbia.edu